comparemela.com

Latest Breaking News On - Allos therapeutics - Page 2 : comparemela.com

LAVA Therapeutics Announces the Appointment of Dr Charles Morris as Chief Medical Officer

UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 LAVA Therapeutics N.V. , an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific. | February 6, 2023

LAVA Therapeutics Announces the Appointment of Dr Charles Morris as Chief Medical Officer

06.02.2023 - UTRECT, The Netherlands and PHILADELPHIA, Feb. 06, 2023 (GLOBE NEWSWIRE) - LAVA Therapeutics N.V. (Nasdaq LVTX), an immuno-oncology company focused on developing its proprietary Gammabody platform of bispecific gamma-delta T cell engagers to . Seite 1

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.